Search results
Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
AOL· 21 hours agoAmgen's (AMGN) positive trial results update on its GLP-1 injectable for obesity, MariTide, sent its stock up more than 13% in trading Friday. CEO Bob Bradway shared a peek ...
Wegovy, an injectable medication used to treat obesity, will now be available in Canada. Here's what...
Yahoo Canada Style· 2 days agoPerspectives Wegovy users are advised to modify their diet and exercise. (Image via Getty Images)...
Amgen axes obesity asset after phase 1 results, zooms in on MariTide
FierceBiotech· 2 days agoAmgen is axing obesity candidate AMG 786 and going all in on later-stage asset MariTide. “Given the...
Novo Slides as Amgen Fuels Obesity Drug Competition Fears
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- Novo Nordisk A/S shares fell as a US rival’s comments on an experimental obesity drug...
Protect judges, Hamas protesters, treating obesity, Templeton should focus on son | Letters
The Post and Courier· 1 day agoWith respect to the February Post and Courier article, “SC weight loss experts discuss off-label use...
Small Bowel Microbiome Profiles Differ in Overweight/Obesity
Medscape· 2 days agoResearchers have identified significant and specific variations in the microbial universe of the...
Amgen soars 16% after it talks up a new weight loss drug that could be injected monthly instead of...
Business Insider via Yahoo Finance· 17 hours agoBut demand is so strong that supply has been constrained, and Wall Street analysts believe the total...
Amgen Stock Jumps on Obesity Drug Optimism. What Comes Next.
Barrons.com· 1 day agoAmgen is trying to carve a niche in a rapidly growing obesity-drug market that’s currently dominated...
So you've lost weight using Wegovy. Does that mean you can stop taking it?
San Francisco Chronicle· 3 days agoMillions of Americans who have dropped pounds and boosted their health using popular obesity drugs...
Novo Slides as Amgen Fuels Obesity Drug Competition Fears
Bloomberg· 1 day agoHave a confidential tip for our reporters? Novo Nordisk A/S shares fell as a US rival’s comments on...